Annual Accounts Payable
$2.58 M
+$2.32 M+890.77%
December 31, 2023
Summary
- As of February 7, 2025, DAWN annual accounts payable is $2.58 million, with the most recent change of +$2.32 million (+890.77%) on December 31, 2023.
- During the last 3 years, DAWN annual accounts payable has risen by +$2.37 million (+1175.25%).
- DAWN annual accounts payable is now at all-time high.
Performance
DAWN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.02 M
-$3.43 M-53.18%
September 30, 2024
Summary
- As of February 7, 2025, DAWN quarterly accounts payable is $3.02 million, with the most recent change of -$3.43 million (-53.18%) on September 30, 2024.
- Over the past year, DAWN quarterly accounts payable has increased by +$441.00 thousand (+17.12%).
- DAWN quarterly accounts payable is now -53.18% below its all-time high of $6.44 million, reached on June 30, 2024.
Performance
DAWN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
DAWN Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +890.8% | +17.1% |
| 3 y3 years | +1175.3% | -24.1% |
| 5 y5 years | +3633.3% | -24.1% |
DAWN Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +890.8% | -53.2% | +1060.4% |
| 5 y | 5-year | at high | +3633.3% | -53.2% | +1393.6% |
| alltime | all time | at high | +3633.3% | -53.2% | +1393.6% |
Day One Biopharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.02 M(-53.2%) |
| Jun 2024 | - | $6.44 M(+34.8%) |
| Mar 2024 | - | $4.78 M(+85.6%) |
| Dec 2023 | $2.58 M(+890.8%) | $2.58 M(-24.0%) |
| Sep 2023 | - | $3.39 M(-25.7%) |
| Jun 2023 | - | $4.57 M(-2.0%) |
| Mar 2023 | - | $4.66 M(+1691.2%) |
| Dec 2022 | $260.00 K | $260.00 K(-93.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $3.97 M(+805.0%) |
| Jun 2022 | - | $439.00 K(-37.4%) |
| Mar 2022 | - | $701.00 K(-59.8%) |
| Dec 2021 | $1.74 M(+763.4%) | $1.74 M(+155.3%) |
| Sep 2021 | - | $683.00 K(+96.3%) |
| Jun 2021 | - | $348.00 K(-49.3%) |
| Mar 2021 | - | $686.00 K(+239.6%) |
| Dec 2020 | $202.00 K(+192.8%) | $202.00 K |
| Dec 2019 | $69.00 K | - |
FAQ
- What is Day One Biopharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual accounts payable year-on-year change?
- What is Day One Biopharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly accounts payable year-on-year change?
What is Day One Biopharmaceuticals annual accounts payable?
The current annual accounts payable of DAWN is $2.58 M
What is the all time high annual accounts payable for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual accounts payable is $2.58 M
What is Day One Biopharmaceuticals annual accounts payable year-on-year change?
Over the past year, DAWN annual accounts payable has changed by +$2.32 M (+890.77%)
What is Day One Biopharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of DAWN is $3.02 M
What is the all time high quarterly accounts payable for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly accounts payable is $6.44 M
What is Day One Biopharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, DAWN quarterly accounts payable has changed by +$441.00 K (+17.12%)